Sign in
4

Changes in Ownership

Bioventus Inc. Filed Acc 0000899243-23-008792

Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)

  • Chief Executive Officer acquired 28,721 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Reali Kenneth Michael · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-14 Exercise or conversion : show line 1 in the form +28,721 39,896 D
2023-03-15 Sale : show line 2 in the form −9,811 $1.39 $13,625 30,085 D
Open-market sales · 9,811 sh · avg $1.39 · $13,625

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-14 Grant or award : show line 3 in the form Restricted Stock Units +114,882 114,882 D
2023-03-14 Exercise or conversion : show line 4 in the form Restricted Stock Units −28,721 86,161 D
Loading xslF345X03/doc4.xml…